Skip Nav Destination
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
EZH2 mutational status predicts poor survival in myelofibrosis
Blood CD34−c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Issue Archive
November 10 2011
In this Issue
Table of Contents
Inside Blood
Plenary Paper
Red Cells, Iron, and Erythropoiesis
Proof of principle for transfusion of in vitro–generated red blood cells
Marie-Catherine Giarratana,Hélène Rouard,Agnès Dumont,Laurent Kiger,Innocent Safeukui,Pierre-Yves Le Pennec,Sabine François,Germain Trugnan,Thierry Peyrard,Tiffany Marie,Séverine Jolly,Nicolas Hebert,Christelle Mazurier,Nathalie Mario,Laurence Harmand,Hélène Lapillonne,Jean-Yves Devaux,Luc Douay
Perspectives
Review Article
Blood Consult
Gene Therapy
Immunobiology
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients
Clinical Trials & Observations
Monia Ouederni,Quentin B. Vincent,Pierre Frange,Fabien Touzot,Sami Scerra,Mohamed Bejaoui,Aziz Bousfiha,Yves Levy,Barbara Lisowska-Grospierre,Danielle Canioni,Julie Bruneau,Marianne Debré,Stéphane Blanche,Laurent Abel,Jean-Laurent Casanova,Alain Fischer,Capucine Picard
CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
Vanja Sisirak,Nelly Vey,Béatrice Vanbervliet,Thomas Duhen,Isabelle Puisieux,Bernhard Homey,Edward P. Bowman,Giorgio Trinchieri,Bertrand Dubois,Dominique Kaiserlian,Sergio A. Lira,Alain Puisieux,Jean-Yves Blay,Christophe Caux,Nathalie Bendriss-Vermare
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis
Adriano Boasso,Caroline M. Royle,Spyridon Doumazos,Veronica N. Aquino,Mara Biasin,Luca Piacentini,Barbara Tavano,Dietmar Fuchs,Francesco Mazzotta,Sergio Lo Caputo,Gene M. Shearer,Mario Clerici,David R. Graham
Lymphoid Neoplasia
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study
Clinical Trials & Observations
Raouf Ben Abdelali,Vahid Asnafi,Thibaut Leguay,Nicolas Boissel,Agnès Buzyn,Patrice Chevallier,Xavier Thomas,Stephane Lepretre,Françoise Huguet,Norbert Vey,Martine Escoffre-Barbe,Emmanuelle Tavernier,Oumedaly Reman,Nathalie Fegueux,Pascal Turlure,Philippe Rousselot,Jean-Yves Cahn,Veronique Lheritier,Yves Chalandon,Marie-Christine Béné,Elizabeth Macintyre,Hervé Dombret,Norbert Ifrah,for the Group for Research on Adult Acute Lymphoblastic Leukemia
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
Clinical Trials & Observations
Todd A. Fehniger,Sarah Larson,Kathryn Trinkaus,Marilyn J. Siegel,Amanda F. Cashen,Kristie A. Blum,Timothy S. Fenske,David D. Hurd,Andre Goy,Stephanie E. Schneider,Catherine R. Keppel,Nina D. Wagner-Johnston,Kenneth R. Carson,Nancy L. Bartlett
Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups
Xin Huang,Kushi Kushekhar,Ilja Nolte,Wierd Kooistra,Lydia Visser,Ilby Bouwman,Niels Kouprie,Rianne Veenstra,Gustaaf van Imhoff,Bianca Olver,Richard S. Houlston,Sibrand Poppema,Arjan Diepstra,Bouke Hepkema,Anke van den Berg
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
Laura E. Hogan,Julia A. Meyer,Jun Yang,Jinhua Wang,Nicholas Wong,Wenjian Yang,Gregory Condos,Stephen P. Hunger,Elizabeth Raetz,Richard Saffery,Mary V. Relling,Deepa Bhojwani,Debra J. Morrison,William L. Carroll
Myeloid Neoplasia
EZH2 mutational status predicts poor survival in myelofibrosis
Clinical Trials & Observations
Paola Guglielmelli,Flavia Biamonte,Joannah Score,Claire Hidalgo-Curtis,Francisco Cervantes,Margherita Maffioli,Tiziana Fanelli,Thomas Ernst,Nils Winkelman,Amy V. Jones,Katerina Zoi,Andreas Reiter,Andrew Duncombe,Laura Villani,Alberto Bosi,Giovanni Barosi,Nicholas C. P. Cross,Alessandro M. Vannucchi
Blood CD34−c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor
Brief Report
Sophie Georgin-Lavialle,Ludovic Lhermitte,Cédric Baude,Stéphane Barete,Julie Bruneau,Jean-Marie Launay,Marie-Olivia Chandesris,Katia Hanssens,Christian de Gennes,Gandhi Damaj,Fanny Lanternier,Mohamed Hamidou,Olivier Lortholary,Patrice Dubreuil,Frédéric Feger,Yves Lepelletier,Olivier Hermine
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Brief Report
Thomas O'Hare,Matthew S. Zabriskie,Christopher A. Eide,Anupriya Agarwal,Lauren T. Adrian,Huihong You,Amie S. Corbin,Fei Yang,Richard D. Press,Victor M. Rivera,Julie Toplin,Stephane Wong,Michael W. Deininger,Brian J. Druker
Phagocytes, Granulocytes, and Myelopoiesis
Platelets and Thrombopoiesis
Red Cells, Iron, and Erythropoiesis
Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome
Joanna F. Flatt,Hélène Guizouarn,Nicholas M. Burton,Franck Borgese,Richard J. Tomlinson,Robert J. Forsyth,Stephen A. Baldwin,Bari E. Levinson,Philippe Quittet,Patricia Aguilar-Martinez,Jean Delaunay,Gordon W. Stewart,Lesley J. Bruce
Thrombosis and Hemostasis
Transplantation
Vascular Biology
-
Cover Image
Cover Image
The cover shows a phase contrast image of normal human erythrocytes, overlaid with the fluorescence images stained with antibodies to the glucose transporter 1 (glut1, red) and to stomatin (green). The predominantly yellow staining pattern suggests that glut1 and stomatin colocalize in the erythrocyte membrane. See the article by Bruce et al on page 5267.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals